Sales and Marketing

Showing 15 posts of 11524 posts found.

Schering-Plough’s new anti-fungal gains EMEA approval

July 29, 2005 Sales and Marketing

A new treatment for fungal infections has been given a positive opinion by the EMEA.Schering-Plough's Noxafil (posaconazole) is a novel …

New drug-resistant HIV treatment recommended

July 28, 2005 Sales and Marketing

Boehringer Ingelheim's new treatment for patients with drug-resistant HIV has been recommended for approval by the European regulator.The prevalence of …

New 28-day pack for Cozaar launched

July 20, 2005 Sales and Marketing

A new 28-day pack of Merck Sharp & Dohme's top-selling hypertension treatment Cozaar has been launched in the UK.The 50mg …

Arixtra approved for new blood clot indication

July 20, 2005 Sales and Marketing Arixtra, GlaxoSmithKline

GlaxoSmithKline’s Arixtra has gained approval for use in preventing blood clots in high-risk patients undergoing abdominal surgery.The drug is already …

Iressa successor enters phase III

July 19, 2005 Research and Development, Sales and Marketing

AstraZeneca's oncology compound ZD6474 has entered phase III trials after positive results in trials in non-small cell lung cancer.The drug, …

Getting inside the customer’s head

July 11, 2005 Sales and Marketing

Doctors are a diverse group of people. From GPs to specialists, with the more than 60 areas of medicine that …

ABPI sets up links to clinical trials databases

July 7, 2005 Sales and Marketing

Website links to details of more than 4,000 clinical trials have been published by the ABPI, as the global agreement …

Pfizer pulls out of Daxas collaboration

July 7, 2005 Sales and Marketing Daxas, Nycomed, Pfizer

Pfizer has pulled out of an agreement with Altana Pharma to develop and market a new treatment for asthma and …

One Europe for pharma marketers?

July 6, 2005 Sales and Marketing

Pharma economists will tell you that the world has a market 'top three'. The US is way ahead in the …

No more Alton Towers? UK pharma downsizes its hospitality

July 6, 2005 Sales and Marketing

UK-based pharmaceutical companies have pre-empted strict new European rules on entertaining healthcare professionals by imposing their own restrictions.The companies are …

Lilly buys rights to novel diabetes drug

July 6, 2005 Research and Development, Sales and Marketing

Eli Lilly has signed a licensing agreement with Japanese pharmaceutical company Taisho for TS-021, a novel treatment for type II …

Antidepressants come under FDA review again

July 4, 2005 Sales and Marketing

The FDA is conducting another review of antidepressants to determine whether the drugs increase the risk of suicidal behaviour in …
The Gateway to Local Adoption Series

Latest content